| Literature DB >> 33928432 |
Julia Schumacher1, John-Paul Taylor2, Calum A Hamilton2, Michael Firbank2, Paul C Donaghy2, Gemma Roberts2, Louise Allan2,3, Rory Durcan2, Nicola Barnett2, John T O'Brien4, Alan J Thomas2.
Abstract
Previous resting-state fMRI studies in dementia with Lewy bodies have described changes in functional connectivity in networks related to cognition, motor function, and attention as well as alterations in connectivity dynamics. However, whether these changes occur early in the course of the disease and are already evident at the stage of mild cognitive impairment is not clear. We studied resting-state fMRI data from 31 patients with mild cognitive impairment with Lewy bodies compared to 28 patients with mild cognitive impairment due to Alzheimer's disease and 24 age-matched controls. We compared the groups with respect to within- and between-network functional connectivity. Additionally, we applied two different approaches to study dynamic functional connectivity (sliding-window analysis and leading eigenvector dynamic analysis). We did not find any significant changes in the mild cognitive impairment groups compared to controls and no differences between the two mild cognitive impairment groups, using static as well as dynamic connectivity measures. While patients with mild cognitive impairment with Lewy bodies already show clear functional abnormalities on EEG measures, the fMRI analyses presented here do not appear to be sensitive enough to detect such early and subtle changes in brain function in these patients.Entities:
Keywords: Alzheimer’s disease; Dynamic connectivity; Leading eigenvector dynamic analysis; Lewy body dementia; Resting-state fMRI; Sliding-window analysis
Mesh:
Year: 2021 PMID: 33928432 PMCID: PMC8563567 DOI: 10.1007/s00415-021-10580-z
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 6.682
Fig. 1Included resting-state networks from the UK Biobank group-ICA (d = 21) overlaid on the MNI brain template. Spatial maps are thresholded at 5 < z < 15. Images are shown in radiological convention, i.e. the right side of the image corresponds to the left hemisphere
Demographic and clinical variables, mean (standard deviation)
| HC ( | MCI-AD ( | MCI-LB ( | Group differences | |
|---|---|---|---|---|
| Male:female | 17:7 | 14:14 | 29:2 | |
| Age | 73.5 (7.6) | 76.2 (7.9) | 74.7 (6.6) | |
| AChEI | – | 5 (19%)e | 14 (47%)f | |
| PD meds | – | 0e | 2 (7%)f | |
| Years of education | 14.5 (3.7)g | 12.9 (3.5) | 12.1 (3.0) | |
| ACE-R | 92.3 (4.4) | 82.2 (8.8) | 83.4 (9.5) | |
| MMSE | 28.3 (1.1) | 27.0 (2.2) | 26.6 (2.6) | |
| UPDRS III | 5.3 (4.3) | 16.2 (15.1) | 22.8 (14.9) | |
| DCFS | – | 6.7 (1.9)h | 8.8 (3.5)i | |
| CAF total | – | 1.3 (2.4)h | 4.2 (4.5)i | |
| NPI total | – | 7.6 (8.3)h | 14.9 (12.6)i | |
| NEVHI | – | 0.6 (1.2)j | 3.3 (4.4) | |
| Mean FD (mm) | 0.25 (0.09) | 0.28 (0.10) | 0.26 (0.11) | |
| Max FD (mm) | 0.94 (0.66) | 1.3 (0.65) | 1.1 (0.73) |
ACE-R Addenbrooke’s Cognitive Examination—Revised, AChEI number of patients taking acetylcholinesterase inhibitors, CAF total Clinician Assessment of Fluctuation total score, DCFS Dementia cognitive fluctuation scale, FD framewise displacement, HC healthy controls, MCI-AD mild cognitive impairment with Alzheimer’s disease, MCI-LB probable mild cognitive impairment with Lewy bodies, MMSE Mini Mental State Examination, NEVHI North-East Visual Hallucinations Interview, NPI Neuropsychiatric Inventory, PD meds number of patients taking dopaminergic medication for the management of Parkinson’s disease symptoms, UPDRS III Unified Parkinson’s Disease Rating Scale III (motor subsection)
aChi-square test HC, MCI-AD, MCI-LB; bUnivariate ANOVA HC, MCI-AD, MCI-LB; cChi-square test MCI-AD, MCI-LB; dStudent’s t test MCI-AD, MCI-LB, eN = 26, fN = 30, gN = 22, hN = 23, iN = 28, jN = 27
Fig. 2Results from sliding-window dynamic functional connectivity analysis. a–c Matrices represent mean standard deviation over time for the HC, MCI-AD, and MCI-LB groups. d Boxplot of group comparison of mean standard deviation across all connections. In the boxplot the central line corresponds to the sample median, the upper and lower border of the box represent the 25th and 75th percentile, respectively, and the length of the whiskers is 1.5 times the interquartile range. DMN default mode network, HC healthy controls, MCI-AD mild cognitive impairment with Alzheimer’s disease, MCI-LB mild cognitive impairment with Lewy bodies
Fig. 3Results from the sliding-window k-means analysis with low-dimensional Biobank RSNs (d = 21). a Centroids resulting from clustering on all windows and participants. The network graphs are showing only the 5% strongest positive (red) and negative (blue) connections. b Cluster medians in the healthy control group. c Cluster medians in the MCI-AD group. d Cluster medians in the MCI-LB group. e Group comparison of the overall number of state transitions. f Group comparison of frequency of occurrence of the three states. g Group comparison of mean time between two state transitions. h Comparison of mean dwell time of the three states. In the boxplots the central line corresponds to the sample median, the upper and lower border of the box represent the 25th and 75th percentile, respectively, and the length of the whiskers is 1.5 times the interquartile range. HC healthy controls, MCI-AD mild cognitive impairment with Alzheimer’s disease, MCI-LB mild cognitive impairment with Lewy bodies
Fig. 4Results from the LEiDA k-means analysis. a Centroids resulting from clustering on all windows and participants, i.e. the outer product of the vector V that represents each cluster centroid. b Group comparison of the overall number of state transitions. c Group comparison of frequency of occurrence of the three states. d Group comparison of mean time between two state transitions. e Comparison of mean dwell time of the three states. In the boxplots the central line corresponds to the sample median, the upper and lower border of the box represent the 25th and 75th percentile, respectively, and the length of the whiskers is 1.5 times the interquartile range. HC healthy controls, MCI-AD mild cognitive impairment with Alzheimer’s disease, MCI-LB mild cognitive impairment with Lewy bodies